Nov 27 (Reuters) – London stocks slipped on Friday, set for their first weekly loss this month on doubts over the efficacy of AstraZeneca’s COVID-19 vaccine and concerns over a post-Brexit trade deal with the European Union. The blue-chip FTSE 100 index UK100 fell 0.7%, while the domestically focussed mid-cap FTSE 250 Continue Reading